Rxsight Inc reports results for the quarter ended June 30 - Earnings Summary

RxSight

08/08/2025 05:29

Rxsight Inc RXST.OQ reported a quarterly adjusted loss of 29 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -16 cents.  The mean expectation of eleven analysts for the quarter was for a loss of 24 cents per share. Wall Street expected results to range from -33 cents to -15 cents per share.

Revenue fell 3.6% to $33.64 million from a year ago; analysts expected $35.19 million.

Rxsight Inc's reported EPS for the quarter was a loss of 29 cents​.

The company reported a quarterly loss of $11.79 million.

Rxsight Inc shares had fallen by 41.9% this quarter and lost 78.0% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 47.7% in the last three months.​

In the last 30 days, six analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 8 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."

Wall Street's median 12-month price target for Rxsight Inc is $9.00, about 13.4% above its last closing price of $7.79

This summary was machine generated from LSEG data August 8 at 04:29 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-0.24
-0.29
Missed
Mar. 31 2025
-0.22
-0.20
Beat
Dec. 31 2024
-0.17
-0.15
Beat
Sep. 30 2024
-0.25
-0.16
Beat